|
|
{{if listFind(vars.channel_names, "MSIF News")}} {{endif}}  {{if listFind(vars.channel_names, "MSIF News")}} {{endif}} {{if listFind(vars.channel_names, "MSIF News")}} 
MSIF News
{{endif}}
|
{{if listFind(vars.channel_names, "People With MS News")}} {{endif}}  {{if listFind(vars.channel_names, "People With MS News")}} {{endif}} {{if listFind(vars.channel_names, "People With MS News")}} 
Profile of the Month
{{endif}}
|
{{if listFind(vars.channel_names, "Research News")}} {{endif}}  {{if listFind(vars.channel_names, "Research News")}} {{endif}} {{if listFind(vars.channel_names, "Research News")}} 
Research News
{{endif}}
|
{{if listFind(vars.channel_names, "MS Society News")}} {{endif}}  {{if listFind(vars.channel_names, "MS Society News")}} {{endif}} {{if listFind(vars.channel_names, "MS Society News")}} 
MS News
{{endif}}
|
|
|
|
Making Connections
|
{{if listFind(vars.channel_names, "MSIF News")}}
|
|
MSIF News
 |
 |
| Summaries of new MSIF activities, events, projects, programmes, resources, publications and more. |
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}
|
|
Profile of the Month
 |
 |
| Summaries of news, views and achievements from people with MS around the world. |
Profile of the Month : June 2008
 Christo Balabanov Country: Bulgaria Age: 49 Profession: Mechanical engineer Type of MS: Secondary progressive Year of diagnosis: 1991
How Multiple Sclerosis changed my life (What I gained and lost from MS)
English Italiano Francais Espanol Russian Deutsche
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}
|
|
Research News
 |
 |
| Summaries of all the latest research findings on MS selected by a team based at the Institute of Neurology, London. |
Gene expression analysis of interferon-{beta} treatment in multiple sclerosis.
The authors found that IFN-beta induced the expression of a large number of genes at the beginning of treatment. Additional studies are needed to clarify which changes in gene expression can account for the immunomodulatory and clinical effects of treatment with IFN-beta.
authors: Sellebjerg F, Datta P, Larsen J, Rieneck K, Alsing I, Oturai A, Svejgaard A, Soelberg Sørensen P, Ryder LP.
source: Mult Scler. 2008 Apr 11 [Epub ahead of print]
read more
Oligodendrocyte-specific protein is encephalitogenic in rhesus macaques and induces specific demyelination of the optic nerve.
The authors investigated the role of Oligodendrocyte-specific protein in the development of experimental autoimmune encephalomyelitis, the animal model of MS. They found that this protein caused selective demyelination of the optic nerve in rhesus monkeys.
authors: Bajramovic JJ, Brok HP, Ouwerling B, Jagessar SA, van Straalen L, Kondova I, Bauer J, Amor S, Hart BA, Ben-Nun A.
source: Eur J Immunol. 2008 Apr 15 [Epub ahead of print]
read more
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}
|
|
MS News
 |
 |
| Summaries of MS news from websites around the world. |
Romania: project to improve the lives of young people with MS
The Romanian MS society is implementing a resolution in collaboration with the European Youth Parliament Romania to the Committee on Social Affairs and Equal Opportunities, designed to help young people with MS. Vladimír Spidla, European Commissioner for Employment, Social Affairs and Equal Opportunities commented, “People with disabilities must become active players in the internal market. It needs to become a reality for all, including people with disabilities. Accessibility to goods, services and infrastructures are a precondition for full enjoyment of fundamental rights of people with disabilities.”
read more
|
{{endif}}
|
|
Tell a friend

The email you subscribed with us is {{print email}}
Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.
If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.
If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here
Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org
|
|